Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Here's who will be speaking in 2018


Ameet Nathwani

Ameet Nathwani

EVP & Chief Medical Officer, Sanofi

Read more

More information coming soon...

Shreeram Aradhye

Shreeram Aradhye

Chief Medical Officer, Global Head of Medical Affairs, Novartis

Read more

More information coming soon...

Joaquin Duato

Joaquin Duato

WorldWide Chairman, Pharmaceuticals, Johnson & Johnson

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

EVP, Global Product and Portfolio Strategy, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Hannelore Grams

Hannelore Grams

Head of Digital Excellence Europe and Canada, Takeda

Read more

More information coming soon...


Mark Mallon

Mark Mallon

Executive Vice President, Global Medical Affairs, Global Product and Portfolio Strategy
AstraZeneca

Read more

More information coming soon...

Sandra Silvestri

Sandra Silvestri

Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit
Sanofi

Read more

More information coming soon...

Thomas D’Hooghe

Thomas D’Hooghe

Vice-President and Head Global Medical Affairs Fertility
Merck

Read more

More information coming soon...

Adam Hill

Adam Hill

Chief Medical Officer
McLaren Applied Technologies

Read more

More information coming soon...

Monica de Abadal

Monica de Abadal

Vice President Global Medical Affairs Services
Ipsen

Read more

More information coming soon...

Antonio Tataranni

Antonio Tataranni

Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit
Sanofi

Read more

More information coming soon...

Martina Muttke

Martina Muttke

Head of International Medical Affairs
Shire

Read more

More information coming soon...

Ludovic Hacopian

Ludovic Hacopian

Worldwide MSL and Field Effectiveness Head
BMS

Read more

More information coming soon...

Pam Bacon

Pam Bacon

Executive Director Medical Affairs
Celgene

Read more

More information coming soon...

Mauricio Silva de Lima

Mauricio Silva de Lima

Vice President, Head of Medical Affairs, Region Europe
Roche

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Victoria Ho

Victoria Ho

Worldwide Field Medical & Communications Lead
Bristol-Myers Squibb

Read more

More information coming soon...

Kumaran Krishnan

Kumaran Krishnan

Associate Director MSL and Digital Transformation
Teva

Read more

More information coming soon...

Emma Booth

Emma Booth

European Medical Head of Strategy and Operations
Amgen

Read more

More information coming soon...

Mike Spencer

Mike Spencer

Head of Real-World Evidence EMEA
Janssen

Read more

More information coming soon...

Felix Jackson

Felix Jackson

Founder
medCrowd

Read more

More information coming soon...

Hubert Bland

Hubert Bland

Country Medical Chair and Medical Head Diabetes and Cardiovascular
Sanofi

Read more

More information coming soon...

Gundula Schneidewind

Gundula Schneidewind

Managing Director Belgium
Takeda

Read more

More information coming soon...

David Montgomery

David Montgomery

Vice President Global Science Exchange
Pfizer Oncology

Read more

More information coming soon...


Ameet Nathwani

Ameet Nathwani

EVP & Chief Medical Officer, Sanofi

Read more

More information coming soon...

Shreeram Aradhye

Shreeram Aradhye

Chief Medical Officer, Global Head of Medical Affairs, Novartis

Read more

More information coming soon...

Joaquin Duato

Joaquin Duato

WorldWide Chairman, Pharmaceuticals, Johnson & Johnson

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

EVP, Global Product and Portfolio Strategy, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Hannelore Grams

Hannelore Grams

Head of Digital Excellence Europe and Canada, Takeda

Read more

More information coming soon...

Mark Mallon

Mark Mallon

Executive Vice President, Global Medical Affairs, Global Product and Portfolio Strategy
AstraZeneca

Read more

More information coming soon...

Sandra Silvestri

Sandra Silvestri

Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit
Sanofi

Read more

More information coming soon...

Thomas D’Hooghe

Thomas D’Hooghe

Vice-President and Head Global Medical Affairs Fertility
Merck

Read more

More information coming soon...

Adam Hill

Adam Hill

Chief Medical Officer
McLaren Applied Technologies

Read more

More information coming soon...

Monica de Abadal

Monica de Abadal

Vice President Global Medical Affairs Services
Ipsen

Read more

More information coming soon...

Antonio Tataranni

Antonio Tataranni

Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit
Sanofi

Read more

More information coming soon...

Martina Muttke

Martina Muttke

Head of International Medical Affairs
Shire

Read more

More information coming soon...

Ludovic Hacopian

Ludovic Hacopian

Worldwide MSL and Field Effectiveness Head
BMS

Read more

More information coming soon...

Pam Bacon

Pam Bacon

Executive Director Medical Affairs
Celgene

Read more

More information coming soon...

Mauricio Silva de Lima

Mauricio Silva de Lima

Vice President, Head of Medical Affairs, Region Europe
Roche

Read more

More information coming soon...

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Victoria Ho

Victoria Ho

Worldwide Field Medical & Communications Lead
Bristol-Myers Squibb

Read more

More information coming soon...

Kumaran Krishnan

Kumaran Krishnan

Associate Director MSL and Digital Transformation
Teva

Read more

More information coming soon...

Emma Booth

Emma Booth

European Medical Head of Strategy and Operations
Amgen

Read more

More information coming soon...

Mike Spencer

Mike Spencer

Head of Real-World Evidence EMEA
Janssen

Read more

More information coming soon...

Felix Jackson

Felix Jackson

Founder
medCrowd

Read more

More information coming soon...

Hubert Bland

Hubert Bland

Country Medical Chair and Medical Head Diabetes and Cardiovascular
Sanofi

Read more

More information coming soon...

Gundula Schneidewind

Gundula Schneidewind

Managing Director Belgium
Takeda

Read more

More information coming soon...

David Montgomery

David Montgomery

Vice President Global Science Exchange
Pfizer Oncology

Read more

More information coming soon...

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown